of Screening Compounds
Drug Discovery Services
Pharma News, 2019
Forget ambulances... drones are quicker! Study of rush-hour traffic in New York reveals the gadgets get to patients 32% quicker
Drones can reach critically-ill patients three minutes faster than paramedics in busy cities, according to research.
Amgen escalates PCSK9 pricing war with permanent 60% price cut on Repatha
Amgen's Repatha is facing competition from Regeneron and Sanofi's Praluent, and there could be a new rival in the cholesterol market soon.
GSK ups challenge against AZ, Merck's Lynparza with expanded Zejula ovarian cancer nod
GSK has nabbed an expanded FDA nod for Zejula use in recurrent ovarian cancer beyond those with BRCA mutations as long as the tumor have a homologous recombination deficiency.
WuXi Biologics doubles down on Ireland, will build vaccine plant there
Construction began in May on WuXi Biologics' €325 million biologics plant in Dundalk, Ireland which is forecast to employ up to 400 when it is finished in 2021.
AstraZeneca again raises sales estimates
Cancer drug innovation and Emerging Market sales underlie an upward rerating at AstraZeneca.
Scientists create new test that can tell doctors in just 45 minutes whether a patient is battling a superbug or one that may respond to antibiotics
A test that can tell whether bacteria is resistant to antibiotics in just 45 minutes has been created by scientists.
FDA approves niraparib for HRD-positive advanced ovarian cancer
On October 23, 2019,the Food and Drug Administration approved niraparib (ZEJULA, Tesaro, Inc.
Eli Lilly to target cancer drug developers for deals
(Reuters) - Eli Lilly and Co will target cancer drug developers for deals, Chief Executive Officer Dave Ricks said on a post-earnings conference call on Wednesday.
Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar
NEW YORK/BOSTON (Reuters) - Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.
Drugstore drones: UPS will fly CVS prescriptions to U.S. customers
LOS ANGELES (Reuters) - United Parcel Service Inc’s (UPS.
Researchers grow muscle cells on edible fibers
You can see the long, thin fibers of skeleton muscle in this close-up of prosciutto ham.
FDA approves new drug for most common form of cystic fibrosis
Trikafta (elexacaftor/ivacaftor/tezacaftor) is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation.
Go to cart
You will be able to Pay Online or Request a Quote
Catalog of Screening Compounds
Focused and Target Libraries
Active Reference Sets
Drug Discovery Services
In silico Drug Design (CADD)
Toxicology and Safety
Chemistry, Manufacturing and Controls
News & Media
Trends in discovery compounds